ha14-1 has been researched along with Neoplasms in 3 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marzo, I | 1 |
| Naval, J | 1 |
| Liu, W | 1 |
| Bulgaru, A | 1 |
| Haigentz, M | 1 |
| Stein, CA | 1 |
| Perez-Soler, R | 1 |
| Mani, S | 1 |
| Del Bufalo, D | 1 |
| Rizzo, A | 1 |
| Trisciuoglio, D | 1 |
| Cardinali, G | 1 |
| Torrisi, MR | 1 |
| Zangemeister-Wittke, U | 1 |
| Zupi, G | 1 |
| Biroccio, A | 1 |
1 review available for ha14-1 and Neoplasms
| Article | Year |
|---|---|
The BCL2-family of protein ligands as cancer drugs: the next generation of therapeutics.
Topics: Antimycin A; Antineoplastic Agents; Apoptosis; Benzopyrans; Humans; Ligands; Models, Molecular; Mole | 2003 |
2 other studies available for ha14-1 and Neoplasms
| Article | Year |
|---|---|
Bcl-2 family members as molecular targets in cancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Benzopyrans; BH3 Interacting Domain Death Agonist Protein; Biologi | 2008 |
Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function.
Topics: Apoptosis; Benzopyrans; Blotting, Western; Cell Line, Tumor; DNA-Binding Proteins; Genes, p53; HCT11 | 2005 |